Deep knowledge on
small-molecule drugs and
the 100,000 global patents
covering them

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

How are People Using DrugPatentWatch?

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: SYNTHROID

« Back to Dashboard
Synthroid is a drug marketed by Abbvie and is included in one NDA. It is available from nine suppliers.

The generic ingredient in SYNTHROID is levothyroxine sodium. There are seven drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

Summary for Tradename: SYNTHROID

Suppliers / Packagers: see list122
2013 Sales:$858,725,000

Pharmacology for Tradename: SYNTHROID

Drug Classl-Thyroxine

Clinical Trials for: SYNTHROID

Mean Percentage of Levothyroxine Dosage Increase in Patients With Hypothyroidism Started on Enteral Feeding
Status: Not yet recruiting Condition: Hypothyroidism

Combined Levothyroxine/Liothyronine Supplementation in Hypothyroid Patients With Brain Tumors
Status: Terminated Condition: Hypothyroidism; Brain Tumor

Thyroid Hormone Dose Adjustment in Pregnancy
Status: Recruiting Condition: Pregnancy; Hypothyroidism

Evaluation of the Efficacy and Safety of Levothyroxine in Brain Death Organ Donors: a Randomized Controled Trial
Status: Recruiting Condition: Brain Dead Organ Donors

Is Levothyroxine Alone Adequate Thyroid Hormone Replacement?
Status: Not yet recruiting Condition: Postsurgical Hypothyroidism; Hypothyroidism

Desiccated Thyroid Extract and Levothyroxine for Hypothyroidism Treatment
Status: Recruiting Condition: Primary Hypothyroidism.

Levothyroxine Treatment for Subclinical Hypothyroidism After Head and Neck Surgery
Status: Not yet recruiting Condition: Hypothyroidism; Neoplasms; Postoperative Complications

Fasting Study of Levothyroxine Sodium Tablets 200 mg to Synthroid Tablets 200 mg
Status: Completed Condition: Healthy

Fasting Study of Levothyroxine Sodium Tablets 300 μg to Synthroid® Tablets 300 μg
Status: Completed Condition: Healthy

Fasting Study of Levothyroxine Sodium Tablets 300 Mcg to Synthroid® Tablets 300 Mcg
Status: Completed Condition: Healthy

Courtesy of
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
levothyroxine sodium
TABLET;ORAL021402-001Jul 24, 2002RXNo<disabled><disabled>
levothyroxine sodium
TABLET;ORAL021402-007Jul 24, 2002RXNo<disabled><disabled>
levothyroxine sodium
TABLET;ORAL021402-004Jul 24, 2002RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn